Hadden, John W.,Signorelli, Kathy,Egan, James,Naylor, Paul
申请号：
AU2013203561
公开号：
AU2013203561A1
申请日:
2013.04.10
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2013203561A120130502.pdf#####ABSTRACT A composition for treating cancer, including synergistic amounts of a primary cellderived biologic having the cytokines IL-1, IL-2, IL-6, IL-8, TNF-a, and IFN-y, and a cancer vaccine having at least one antigen. A composition comprising synergistic amounts of the primary cell-derived biologic in combination with at least one adjuvant. A method of treating cancer by administering the composition. A method of reversing immune suppression and gaining immunity to cancer. A method of producing an immune response to an exogenous antigen. A method of enhancing an immune response in a patient by administering the primary cell-derived biologic in combination with at least one adjuvant, and enhancing the immune response of the patient by a synergistic interaction of the primary cell-derived biologic and the adjuvant. A method of increasing function of an immune system.
